Documenti di Didattica
Documenti di Professioni
Documenti di Cultura
55
emedicine.medscape.com
Generalized Tonic-Clonic
Seizures
Updated: Nov 27, 2017
Author: David Y Ko, MD; Chief Editor: Selim R Benbadis, MD
Overview
Background
A seizure is an abnormal paroxysmal discharge of cerebral neurons due to cortical hyperexcitability. The new
International Classification of Seizures divides seizures into 3 categories: generalized onset, focal onset (formerly
partial seizures) and unknown onset.[8] This article uses the term "partial seizures" throughout although the term focal
is now the official term. However, many patients and practitioners are using old terminology.
Partial seizures result from a seizure discharge within a particular brain region or focus, and they manifest focal
symptoms and may progress to secondarily generalized seizure (now called bilateral tonic clonic, with the term
generalization reserved for primary generalized seizure only).[8] Primary generalized seizures probably begin in the
thalamus and other subcortical structures, but on scalp electroencephalographic (EEG) recordings, they may appear to
start simultaneously in both cerebral hemispheres; therefore, they manifest symptoms bilaterally in the body and are
always associated with loss of consciousness.
Partial seizures can generalize secondarily and result in tonic-clonic activity. Some partial seizures have very rapid
generalization, and the partial phase of the seizure may not be readily apparent clinically or even on scalp EEG
recordings. Some partial seizures may have an aura (the new classification discourages the use of aura and suggests
the term simple focal seizure aware instead), but primary generalized seizures usually do not. However, secondarily
generalized partial seizures (now called focal with bilateral tonic clonic in the new classification) are not included in the
category of generalized seizures, which includes only primary generalized seizures.
Generalized seizures can be classified as atonic, tonic, clonic, tonic-clonic, myoclonic, or absence on the basis of
clinical symptoms and EEG abnormalities. Tonic seizure is the rigid contracture of muscles, including respiratory
muscles, which is usually brief. The clonic component is the rhythmic shaking that occurs and is longer. Together, a
generalized tonic-clonic seizure (GTCS) is also called a grand mal seizure and is one of the most dramatic of all
medical conditions.
https://emedicine.medscape.com/article/1184608-print Page 1 of 15
21/03/20 19.55
Patients with generalized tonic-clonic seizures and idiopathic generalized epilepsy typically have no evidence of any
localized, regional, or diffuse brain abnormality on history, physical, or neurologic examination; clinical laboratory
testing; or imaging studies. The awake EEG of patients with generalized tonic-clonic seizure may be normal; however,
certain specific interictal EEG patterns can be distinctive of generalized epilepsy syndromes (see Workup). In
generalized seizure patients, the activation of photic stimulation and/or hyperventilation during an EEG may produce
spikes or even seizures.
A number of medications are used for the treatment of generalized tonic-clonic seizures. The choice of drug should be
tailored to the individual patient and to the epilepsy syndrome, not only to the seizure type (see Treatment and
Management, as well as Medication).
Go to Epilepsy and Seizures, First Adult Seizure, and First Pediatric Seizure for an overview of these topics.
Pathophysiology
Generalized epilepsy is thought to be initiated by 3 different mechanisms:
Physiologically, a seizure results from a paroxysmal high-voltage electrical discharge of susceptible neurons within an
epileptogenic focus. These neurons are known to be hyperexcitable and, for unknown reasons, remain in a state of
partial depolarization.
The neurons surrounding the epileptogenic focus are GABA-ergic (ie, they release gamma-aminobutyric acid) and
hyperpolarized, and they inhibit the epileptogenic neurons. At times, when the epileptogenic neurons overcome the
surrounding inhibitory influence, the seizure discharge spreads to neighboring cortical structures and then to
subcortical and brainstem structures.
Various animal models of generalized epilepsy implicate brainstem structures in the pathogenesis of generalized
seizures. These brainstem structures include the following:
A lateral geniculate body, which produces a generalized tonic-clonic seizure when kindled in the cat
The substantia nigra, including a nigrotectal GABA-ergic projection and locus ceruleus
The spread of excitability to subcortical, thalamic, brainstem, and spinal cord structures corresponds with the tonic
phase of the seizure. Following this, an inhibitory impulse starts from the thalamus and interrupts the tonic phase into
discontinuous bursts of electrical activity, known as the clonic phase.
Etiology
Most generalized epilepsies are idiopathic. However, a definite genetic locus has been found for some of these
generalized types of epilepsy.
Benign familial neonatal convulsion is an autosomal dominant condition with high penetrance, resulting from mutations
in a voltage-gated potassium channel gene, named KCNQ2, in chromosome 20. This gene is homologous to a gene
(ie, KCNQ1) expressed in the heart, mutations of which are responsible for one form of the long QT syndrome. A
channelopathy in the sodium channel b1 subunit (SCN1B) is associated with generalized epilepsy with febrile
https://emedicine.medscape.com/article/1184608-print Page 2 of 15
21/03/20 19.55
convulsions.
Unverricht-Lundborg disease, a progressive myoclonic epilepsy, is an autosomal recessive inherited disorder linked to
chromosome arm 21q. The specific gene was identified recently as cystatin B, an intracellular protease inhibitor. For
most of the other syndromes considered idiopathic generalized epilepsies, more than one gene is thought to be
responsible.
Epidemiology
The age-adjusted incidence of epilepsy (ie, recurrent unprovoked seizures) ranges from 24-53 per 100,000 population
per year. Approximately 20-25% of cases are classified as generalized seizures. The age-adjusted prevalence of
epilepsy ranges from 4-8 per 1000 people.
Developing countries have similar incidences of epilepsy, ranging from 14-57 cases per 1000 population, based on
World Health Organization statistics. Internationally, as in the United States, partial seizures are the most common, but
generalized tonic-clonic seizures still make up a significant percentage of seizures (20-25%).
Generalized convulsive seizures are uncommon in infants and rare in neonates. In elderly patients, generalized tonic-
clonic seizures are usually due to secondary generalization of seizures emanating from localized brain lesions.
Prognosis
The morbidity for tonic-clonic seizure can be high because these patients experience no aura and thus the seizure
strikes without warning; minor injuries are frequent. Patients can have posterior shoulder dislocations and broken
bones.
Aspiration pneumonia
Cardiac arrhythmias
Sudden death
Mortality rates for seizures are low, but, amongst the epilepsies, rates for tonic-clonic seizures are higher. The
incidence of sudden death is 24 times higher in persons with epilepsy than in the general population. Some of the risk
factors for sudden death in epilepsy (SUDEP) include high seizure frequency (specifically tonic-clonic type), younger
age, mental retardation, and polytherapy.[1]
Patient Education
For patient education information, see the Brain and Nervous System Center, as well as Epilepsy.
https://emedicine.medscape.com/article/1184608-print Page 3 of 15
21/03/20 19.55
Presentation
History
Patients with generalized tonic-clonic seizures may report having a prodrome, which comprises premonitory symptoms
occurring hours or days before a seizure. Common prodromes include mood changes, sleep disturbances,
lightheadedness, anxiety, irritability, difficulty concentrating and, rarely, an ecstatic feeling.
Patients with generalized tonic-clonic seizures do not have auras. An aura represents a simple partial seizure/focal
aware seizure, and a reliable history of aura identifies the seizure as partial and not generalized. For seizures that
arise out of sleep (nocturnal seizures), it may be hard to distinguish a primary generalized seizure from a partial
seizure with secondary generalization.
Other symptoms that have been described less consistently are abdominal pain, facial pallor, or headache. Witnesses
of a patient's seizure should be asked about the stereotypical ictal cry, which is strongly associated with generalized
tonic-clonic seizures.[2]
Physical Examination
The patient may have completely nonfocal findings on neurologic examination when not having seizures. Seizures
typically are divided into tonic, clonic, and postictal phases, which are described in detail in this section.
Tonic phase
This stage lasts for 10-20 seconds. Generalized convulsive seizures may begin with myoclonic jerks or, rarely, with
absences. The tonic phase begins with flexion of the trunk and elevation and abduction of the elbows. Subsequent
extension of the back and neck is followed by extension of arms and legs. This can be accompanied by apnea, which
is secondary to laryngeal spasm.
Autonomic signs are common during this phase and include increase in pulse rate and blood pressure, profuse
sweating, and tracheobronchial hypersecretion. Although urinary bladder pressure rises, voiding does not occur
because of sphincter muscle contraction.
Clonic phase
The tonic stage gives way to clonic convulsive movements, in which the tonic muscles relax intermittently for a variable
period of time.
During the clonic stage, a generalized movement occurs at a rate of about 4-8 Hz. This is because phases of atonia
alternate with repeated violent flexor spasms. Each spasm is accompanied by pupillary contraction and dilation. Some
patients may bite their tongue or cheek.
The atonic periods gradually become longer until the last spasm. Voiding may occur at the end of the clonic phase as
sphincter muscles relax. The atonic period lasts about 30 seconds. The patient continues to be apneic during this
phase.
The convulsion, including tonic and clonic phases, lasts around 1-2 minutes.
Postictal state
The postictal state includes a variable period of decreased consciousness during which the patient becomes quiet and
https://emedicine.medscape.com/article/1184608-print Page 4 of 15
21/03/20 19.55
breathing resumes. The patient gradually awakens, often after a period of stupor or sleep, and often is confused, with
some automatic behavior. Headache and muscular pain are common. The patient does not recall the seizure itself.
Complications
Seizures may lead to injuries, including falls, shoulder dislocation, burns, fractures, oral/tongue trauma, and urinary or
bowel incontinence. Loss of memory and postictal state and even brain injury may result, as well as aspiration
pneumonia, and if prolonged, rhabdomyolysis. If a seizure does not stop, it can lead to status epilepticus. There may
be an increased risk of Sudden Unexplained Death in Epilepsy (SUDEP).
DDx
Diagnostic Considerations
The following conditions should be considered in the assessment of patients with possible generalized tonic-clonic
seizures:
Paroxysmal dyskinesias[3]
In infants, apneic syndromes including gastroesophageal reflux and jitteriness of the newborn
In toddlers and young school-aged children, simple faints and breath-holding spells[3]
Go to Epilepsy and Seizures, First Adult Seizure, and First Pediatric Seizure for an overview of these topics.
Differential Diagnoses
Complex Partial Seizures
Migraine Variants
Narcolepsy
https://emedicine.medscape.com/article/1184608-print Page 5 of 15
21/03/20 19.55
Syncope
Viral Encephalitis
Workup
Workup
Approach Considerations
Patients with generalized tonic-clonic seizures and idiopathic generalized epilepsy typically have no evidence of any
localized, regional, or diffuse brain abnormality on history, physical, or neurologic examination; clinical laboratory
testing; or imaging studies.
Imaging studies may not be necessary in a small subgroup of patients with a clear history of myoclonic epilepsy and
absence, with classic 4- to 5-Hz polyspike and wave and EEG from which the diagnosis of a generalized epilepsy
syndrome such as juvenile myoclonic epilepsy can be made with reasonable certainty (along with other supporting
evidence, nonfocal neurologic examination findings, and a family history of seizures), because the likelihood of finding
an abnormality on imaging is very low.
In practice, however, complete certainty is not possible. Therefore, brain imaging may be obtained in the workup of
patients with primary generalized epilepsy if there is a suspicion of focal to bilateral tonic clonic seizures (the
secondarily generalized seizures).
Go to EEG in Common Epilepsy Syndromes, Epileptiform Normal Variants on EEG, and Generalized Epilepsies on
EEG for information on these topics.
Electroencephalography
Interictal EEG
The awake EEG of patients with generalized tonic-clonic seizure may be normal. Hyperventilation, photic stimulation,
sleep-deprivation and/or prolonged EEG can increase the likelihood of finding an abnormality on EEG.
Interictal abnormalities include usually generalized spikes, sharp waves, polyspikes, and polyspike or spike-and-wave
complexes. Paroxysmal frontal intermittent rhythmic delta activity (FIRDA) may be found in some patients, especially
those with a history of absences, but this is a nonspecific abnormality that is not considered epileptiform.
Certain specific interictal EEG patterns can be distinctive of generalized epilepsy syndromes, as follows:
Generalized bilaterally synchronous 3-Hz spike-and-wave complexes are associated with typical absence
attacks
Fast spike-and-wave activity at 4-5 Hz is associated most often with generalized tonic-clonic seizures
Polyspikes or polyspike and slow-wave complexes usually are seen with juvenile myoclonic epilepsy.
Ictal EEG
The tonic phase of convulsion is characterized by progressively higher amplitude and lower frequency discharge
pattern observed simultaneously in both cortical hemispheres, reaching a maximum of 10 Hz.
https://emedicine.medscape.com/article/1184608-print Page 6 of 15
21/03/20 19.55
This then becomes slower and mixed with bilateral high-amplitude spikes and a progressively greater amount of high-
amplitude rhythmic delta activity. These are slow, developing progressively into repetitive complexes of high-amplitude
spike-and-slow-wave activity in the clonic phase.
Postictal EEG
The postictal EEG may be isoelectric or may show diffuse, very low amplitude, slow delta activity. This corresponds to
sustained hyperpolarization.
Prolactin Study
Plasma prolactin levels, if measured within 10-20 minutes of a generalized tonic-clonic seizure, are elevated to 5-30
times the baseline values. The baseline level is obtained at the same time of day when the patient is not seizing. The
plasma prolactin level is a useful diagnostic tool to exclude pseudoseizures if the seizure looks like a tonic-clonic
seizure. The prolactin level may not be elevated in absence and myoclonic seizures and in simple and brief complex
partial seizures.
Metabolic acidosis and elevated levels of serum lactate and creatine kinase are common findings after a seizure.
Serum adrenocorticotropic hormone (ACTH), cortisol, vasopressin, growth hormone, and beta-endorphin levels also
are increased postictally but for a very brief duration; therefore, they are not useful clinically.
Computed Tomography
An abnormality on CT scans is rare in patients with primary generalized tonic-clonic seizures. Because CT will not
detect most types of congenital structural brain abnormalities, MRI is the imaging modality of choice.
Lissencephaly
Pachygyria
Subependymal heterotopias
https://emedicine.medscape.com/article/1184608-print Page 7 of 15
21/03/20 19.55
Schizencephaly
Other Tests
If there is a strong family history, or semiology is consistent with certain epilepsy syndromes that are genetic, then
genetic testing may be useful. The genetic epilepsies are increasing and the testing costs are decreasing.
Procedures
The abliity to get ictal studies is increased with ambulatory video EEG and if the events are less frequent then inpatient
video EEG where AED can be reduced or withdrawn to induce typical seizue.
Treatment
Approach Considerations
A number of antiepileptic drugs (AEDs) are used for the treatment of generalized tonic-clonic seizures. The choice of
drug should be tailored to the individual patient and to the epilepsy syndrome, not to the seizure type only.
Go to Epilepsy and Seizures, First Adult Seizure, and First Pediatric Seizure for an overview of these topics.
Anticonvulsant Therapy
Valproic acid has been considered the AED of choice for patients who have multiple seizure types, including
generalized tonic-clonic seizures (except in female patients with reproductive capability), since it treats a broad
spectrum of seizure types, including myoclonic seizures. The unblinded, randomized, controlled Standard Antiepileptic
and New Antiepileptic Drug (SANAD) study on the effectiveness of valproate, lamotrigine, or topiramate for
generalized and unclassifiable epilepsy supported the primacy of valproate.[4] The selection of AED has to be
https://emedicine.medscape.com/article/1184608-print Page 8 of 15
21/03/20 19.55
personalized for each patient due to side-effect profile (e.g., valproic acid can cause weight gain, so if the patient is
obese it can worsen that medical issue).
Phenytoin and carbamazepine are reasonable second options among the older group of AEDs for partial to
secondarily generalized seizures (focal to bilateral tonic clonic seizures). However, the newer medications (e.g.,
lamotrigine, topiramate, zonisamide,[5] levetiracetam) tend to work as well if not better and have better side-effect
profiles, especially regarding long-term side effects. Phenobarbital is still used by many neurologists, though its
adverse cognitive effects have led to a decline in its use.
Perampanel (Fycompa) is approved as adjunctive treatment for primary generalized tonic-clonic seizures in adults and
children aged 12 years or older. Perampanel has also shown good efficacy in reducing partial seizures with secondary
generalization.
The AED rufinamide (Banzel) has been approved as adjunctive therapy for seizures associated with Lennox-Gastaut
syndrome (LGS).[6, 7] Another AED, clobazam (Onfi/Frisium), has been useful in seizures associated with LGS as
well in the United States, but worldwide use of this drug for many years also suggests good coverage for primary
generalized tonic-clonic seizures.
For refractory generalized epilepsy, felbamate also is used as an agent of last resort and is very effective. The
potential adverse effects of felbamate necessitate very careful monitoring of blood counts and liver function tests.
Special considerations
Certain AEDs are enzyme inducers and decrease the levels of oral contraceptive agents. Warn patients of this and
advise them to use additional contraceptive precaution while on enzyme-inducing agents such as phenytoin,
carbamazepine, and phenobarbital.
The older first-generation AEDs (e.g., phenytoin, carbamazepine, phenobarbital, valproic acid, and topiramate) have a
teratogenic risk that needs to be considered.
No other surgical option exists for pure generalized tonic-clonic seizures. Patients must be carefully evaluated and
may necessitate video-EEG because some partial seizures with quick secondary bilateral synchrony may be labeled
as primary generalized tonic-clonic.
Ketogenic Diet
A ketogenic diet can be tried to improve seizure control in younger patients whose condition is refractory. The
ketogenic diet was popularized at Johns Hopkins and spread widely. It was based on the observation that seizures
improved during periods of starvation. Studies have shown a substantial reduction in seizure frequency in 50% of
patients placed on the diet.
The exact mechanism by which this diet works is not known. The diet typically contains a fat-to-carbohydrate ratio of
4:1. This diet produces a ketotic state but provides adequate calories for nutrition from proteins and fat.
The ketogenic diet is used for intractable epilepsy, especially in childhood. It is less commonly prescribed for adults
because the diet, being very restrictive, is very difficult to maintain. In adults, a high-protein low-carbohydrate diet is
https://emedicine.medscape.com/article/1184608-print Page 9 of 15
21/03/20 19.55
being studied.
Adverse effects are mainly gastrointestinal and include bloating, constipation, renal stones, and bone and weight loss.
Urinary ketones are checked daily and need to be greater than 4+ (80-160 mg/dL.
In general related to diet, avoid excessive amounts of stimulants such as energy drinks.
Activity Restriction
Driving is restricted if patients are still having seizures affecting safe driving as per particular state laws. In addition,
common-sense restrictions for patients with epilepsy should be followed, such as not operating dangerous equipment,
not swimming alone, and not taking baths unsupervised, among others. Cooking with open flame may be dangerous,
leading to burn injuries.
Surgical Care
Surgical options for primary generalized seizures are limited to vagus nerve stimulation (VNS).
Diet
Epileptic individuals should avoid alcohol due to its potential to interact with AEDs. Alcohol use, if sufficient, can also
lower the seizure threshold.
Medication
Medication Summary
The goals of pharmacotherapy are to reduce seizure frequency, severity, and morbidity and prevent complications with
the least side effects. The agents used for tonic-clonic seizures include anticonvulsants such as valproate, lamotrigine,
levetiracetam, felbamate, topiramate, zonisamide, clobazam, and perampanel.
Anticonvulsant Agents
Class Summary
These agents prevent seizure recurrence and terminate clinical and electrical seizure activity.
Considered the drug of first choice for primary generalized epilepsy, valproate has a very wide spectrum and is
effective in most seizure types, including myoclonic seizures. It has multiple mechanisms of anticonvulsant effects,
including increasing gamma-aminobutyric acid (GABA) levels in brain as well as T-type calcium channel activity, which
is important for absence seizures. The extended-release (ER) formulation allows for once-a-day administration.
Ethotoin (Peganone)
Ethotoin may act in the motor cortex, where it may stabilize the seizure threshold and inhibit the spread of seizure
activity. The activity of the brain stem centers responsible for the tonic phase of grand mal seizures may also be
inhibited.
Lamotrigine has several mechanisms of action that may account for its effectiveness. A major disadvantage is that the
dose has to be increased very slowly over several weeks to minimize the chance of rash, especially if the patient is on
valproic acid.
Zonisamide (Zonegran)
One of newer antiepileptics recently introduced in the US market, zonisamide has been studied extensively in Japan
and Korea and seems to have broad-spectrum properties. It blocks T-type calcium channels, prolongs sodium channel
inactivation, and is a carbonic anhydrase inhibitor.
Felbamate (Felbatol)
Felbamate is approved by the FDA for medically refractory partial seizures and Lennox-Gastaut syndrome. This agent
has multiple mechanisms of action, including (1) inhibition of NMDA-associated sodium channels, (2) potentiation of
GABA-ergic activity, and (3) inhibition of voltage-sensitive sodium channels. It is used only as drug of last resort in
medically refractory cases because of the risk of aplastic anemia and hepatic toxicity, which necessitates regular blood
tests.
https://emedicine.medscape.com/article/1184608-print Page 11 of 15
21/03/20 19.55
has multiple mechanisms of action, including state-dependent sodium channel blocking action; it also potentiates
inhibitory activity of the neurotransmitter GABA. It may block glutamate activity and is a carbonic anhydrase inhibitor.
Rufinamide (Banzel)
An AED that is structurally unrelated to current antiepileptics, rufinamide modulates sodium channel activity,
particularly prolongation of the channel's inactive state. It significantly slows sodium channel recovery and limits
sustained repetitive firing of sodium-dependent action potentials. Rufinamide is indicated for adjunctive treatment of
seizures associated with Lennox-Gastaut syndrome.
Primidone (Mysoline)
Primidone decreases neuron excitability and increases the seizure threshold.
Perampanel (Fycompa)
Perampanel is a noncompetitive antagonist of the alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)
glutamate receptor. It is indicated as adjunctive treatment for primary generalized tonic-clonic seizures and for partial-
onset seizures (with or without secondary generalized seizures) in adults and children aged 12 years or older.
Clobazam (ONFI)
Clobazam is a 1,5-benzodiazepine that possesses potent anticonvulsant properties. May enhance the inhibitory effect
of GABA on neuronal excitability by increasing neuronal membrane permeability to chloride ions. Has been approved
as adjunct treatment for refractory epilepsy, specifically LGS, in pediatric and adult patients.
What is the role of the brainstem in the pathogenesis of generalized tonic-clonic seizures?
https://emedicine.medscape.com/article/1184608-print Page 12 of 15
21/03/20 19.55
Presentation
What are the signs and symptoms of the tonic phase of generalized tonic-clonic seizures?
What are the signs and symptoms of the clonic phase of generalized tonic-clonic seizures?
What are the signs and symptoms of the postictal state of generalized tonic-clonic seizures?
DDX
Which conditions should be included in the differential diagnoses of generalized tonic-clonic seizures?
Workup
What is the role of prolactin studies in the workup of generalized tonic-clonic seizures?
What is the role of lab testing in the workup of generalized tonic-clonic seizures?
What is the role of PET scanning in the workup of generalized tonic-clonic seizures?
What is the role of genetic testing in the workup of generalized tonic-clonic seizures?
What is the role of ambulatory video EEG in the workup of generalized tonic-clonic seizures?
Treatment
What are possible adverse effects of anticonvulsants for the treatment of generalized tonic-clonic seizures?
What is the role of vagus nerve stimulation in the treatment of generalized tonic-clonic seizures?
What is the role of ketogenic diet in the treatment of generalized tonic-clonic seizures?
Which activity modifications are used in the treatment of generalized tonic-clonic seizures?
Which surgical procedures are used in the treatment of generalized tonic-clonic seizures?
Which dietary modifications are used in the treatment of generalized tonic-clonic seizures?
Medications
https://emedicine.medscape.com/article/1184608-print Page 13 of 15
21/03/20 19.55
Which medications in the drug class Anticonvulsant Agents are used in the treatment of Generalized Tonic-Clonic
Seizures?
Author
David Y Ko, MD Associate Professor of Clinical Neurology, Loma Linda University School of Medicine
David Y Ko, MD is a member of the following medical societies: American Academy of Neurology, American Clinical
Neurophysiology Society, American Epilepsy Society
Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: SK<br/>Serve(d) as a
speaker or a member of a speakers bureau for: Eisai, Lundbeck, Sunovion, Supernus, UCB.
Coauthor(s)
Soma Sahai-Srivastava, MD Director of Neurology Ambulatory Care Services, LAC and USC Medical Center;
Assistant Professor, Department of Neurology, Keck School of Medicine of the University of Southern California
Soma Sahai-Srivastava, MD is a member of the following medical societies: American Academy of Neurology,
American Medical Association, American Headache Society
Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of
Pharmacy; Editor-in-Chief, Medscape Drug Reference
Jose E Cavazos, MD, PhD, FAAN, FANA, FACNS, FAES Professor with Tenure, Departments of Neurology,
Neuroscience, and Physiology, Assistant Dean for the MD/PhD Program, Program Director of the Clinical
Neurophysiology Fellowship, University of Texas School of Medicine at San Antonio
Jose E Cavazos, MD, PhD, FAAN, FANA, FACNS, FAES is a member of the following medical societies: American
Academy of Neurology, American Clinical Neurophysiology Society, American Epilepsy Society, American Neurological
Association, Society for Neuroscience
Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Brain Sentinel,
consultant.<br/>Stakeholder (<5%), Co-founder for: Brain Sentinel.
Chief Editor
Selim R Benbadis, MD Professor, Director of Comprehensive Epilepsy Program, Departments of Neurology and
Neurosurgery, Tampa General Hospital, University of South Florida Morsani College of Medicine
Selim R Benbadis, MD is a member of the following medical societies: American Academy of Neurology, American
Academy of Sleep Medicine, American Clinical Neurophysiology Society, American Epilepsy Society, American
Medical Association
Disclosure: Serve(d) as a director, officer, partner, employee, advisor, consultant or trustee for: Ceribell, Eisai,
Greenwich, Growhealthy, LivaNova, Neuropace, SK biopharmaceuticals, Sunovion<br/>Serve(d) as a speaker or a
member of a speakers bureau for: Eisai, Greenwich, LivaNova, Sunovion<br/>Received research grant from: Cavion,
LivaNova, Greenwich, Sunovion, SK biopharmaceuticals, Takeda, UCB.
Additional Contributors
https://emedicine.medscape.com/article/1184608-print Page 14 of 15
21/03/20 19.55
Ramon Diaz-Arrastia, MD, PhD Professor, Department of Neurology, University of Texas Southwestern Medical
Center at Dallas, Southwestern Medical School; Director, North Texas TBI Research Center, Comprehensive Epilepsy
Center, Parkland Memorial Hospital
Ramon Diaz-Arrastia, MD, PhD is a member of the following medical societies: Alpha Omega Alpha, American
Academy of Neurology, New York Academy of Sciences, Phi Beta Kappa
References
1. Walczak TS, Leppik IE, D'Amelio M, Rarick J, So E, Ahman P, et al. Incidence and risk factors in sudden unexpected death
in epilepsy: a prospective cohort study. Neurology. 2001 Feb 27. 56(4):519-25. [Medline].
2. Elzawahry H, Do CS, Lin K, Benbadis SR. The diagnostic utility of the ictal cry. Epilepsy Behav. 2010 Jul. 18(3):306-7.
[Medline].
3. Morrell MJ. Differential diagnosis of seizures. Neurol Clin. 1993 Nov. 11(4):737-54. [Medline].
4. Marson AG, Al-Kharusi AM, Alwaidh M, Appleton R, Baker GA, Chadwick DW, et al. The SANAD study of effectiveness of
valproate, lamotrigine, or topiramate for generalised and unclassifiable epilepsy: an unblinded randomised controlled trial.
Lancet. 2007 Mar 24. 369(9566):1016-26. [Medline]. [Full Text].
5. Peters DH, Sorkin EM. Zonisamide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic
potential in epilepsy. Drugs. 1993 May. 45(5):760-87. [Medline].
6. Kluger G, Bauer B. Role of rufinamide in the management of Lennox-Gastaut syndrome (childhood epileptic
encephalopathy). Neuropsychiatr Dis Treat. 2007 Feb. 3(1):3-11. [Medline]. [Full Text].
7. Glauser T, Kluger G, Sachdeo R, Krauss G, Perdomo C, Arroyo S. Rufinamide for generalized seizures associated with
Lennox-Gastaut syndrome. Neurology. 2008 May 20. 70(21):1950-8. [Medline].
8. Fisher RS. The New Classification of Seizures by the International League Against Epilepsy 2017. Curr Neurol Neurosci
Rep. 2017 Jun. 17 (6):48. [Medline].
https://emedicine.medscape.com/article/1184608-print Page 15 of 15